187 related articles for article (PubMed ID: 17406616)
1. Design and construction of targeted AAVP vectors for mammalian cell transduction.
Hajitou A; Rangel R; Trepel M; Soghomonyan S; Gelovani JG; Alauddin MM; Pasqualini R; Arap W
Nat Protoc; 2007; 2(3):523-31. PubMed ID: 17406616
[TBL] [Abstract][Full Text] [Related]
2. A hybrid vector for ligand-directed tumor targeting and molecular imaging.
Hajitou A; Trepel M; Lilley CE; Soghomonyan S; Alauddin MM; Marini FC; Restel BH; Ozawa MG; Moya CA; Rangel R; Sun Y; Zaoui K; Schmidt M; von Kalle C; Weitzman MD; Gelovani JG; Pasqualini R; Arap W
Cell; 2006 Apr; 125(2):385-98. PubMed ID: 16630824
[TBL] [Abstract][Full Text] [Related]
3. Targeted systemic gene therapy and molecular imaging of cancer contribution of the vascular-targeted AAVP vector.
Hajitou A
Adv Genet; 2010; 69():65-82. PubMed ID: 20807602
[TBL] [Abstract][Full Text] [Related]
4. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
5. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats.
Müller OJ; Schinkel S; Kleinschmidt JA; Katus HA; Bekeredjian R
Gene Ther; 2008 Dec; 15(23):1558-65. PubMed ID: 18615116
[TBL] [Abstract][Full Text] [Related]
7. Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.
Jayandharan GR; Zhong L; Li B; Kachniarz B; Srivastava A
Gene Ther; 2008 Sep; 15(18):1287-93. PubMed ID: 18496572
[TBL] [Abstract][Full Text] [Related]
8. Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo.
Zhong L; Li W; Yang Z; Chen L; Li Y; Qing K; Weigel-Kelley KA; Yoder MC; Shou W; Srivastava A
Gene Ther; 2004 Jul; 11(14):1165-9. PubMed ID: 15164097
[TBL] [Abstract][Full Text] [Related]
9. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.
Natkunarajah M; Trittibach P; McIntosh J; Duran Y; Barker SE; Smith AJ; Nathwani AC; Ali RR
Gene Ther; 2008 Mar; 15(6):463-7. PubMed ID: 18004402
[TBL] [Abstract][Full Text] [Related]
11. Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES.
Delluc-Clavières A; Le Bec C; Van den Berghe L; Conte C; Allo V; Danos O; Prats AC
Gene Ther; 2008 Aug; 15(15):1090-8. PubMed ID: 18369321
[TBL] [Abstract][Full Text] [Related]
12. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
13. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M
Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791
[TBL] [Abstract][Full Text] [Related]
14. Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction.
Sipo I; Fechner H; Pinkert S; Suckau L; Wang X; Weger S; Poller W
Gene Ther; 2007 Sep; 14(18):1319-29. PubMed ID: 17611587
[TBL] [Abstract][Full Text] [Related]
15. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes.
Xu R; Janson CG; Mastakov M; Lawlor P; Young D; Mouravlev A; Fitzsimons H; Choi KL; Ma H; Dragunow M; Leone P; Chen Q; Dicker B; During MJ
Gene Ther; 2001 Sep; 8(17):1323-32. PubMed ID: 11571569
[TBL] [Abstract][Full Text] [Related]
16. Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU.
Soghomonyan S; Hajitou A; Rangel R; Trepel M; Pasqualini R; Arap W; Gelovani JG; Alauddin MM
Nat Protoc; 2007; 2(2):416-23. PubMed ID: 17406603
[TBL] [Abstract][Full Text] [Related]
17. An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.
Smith TL; Souza GR; Sidman RL; Arap W; Pasqualini R
Cancer Gene Ther; 2017 Aug; 24(8):358-360. PubMed ID: 28548103
[TBL] [Abstract][Full Text] [Related]
18. Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy.
Michelfelder S; Lee MK; deLima-Hahn E; Wilmes T; Kaul F; Müller O; Kleinschmidt JA; Trepel M
Exp Hematol; 2007 Dec; 35(12):1766-76. PubMed ID: 17920758
[TBL] [Abstract][Full Text] [Related]
19. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver.
Loiler SA; Conlon TJ; Song S; Tang Q; Warrington KH; Agarwal A; Kapturczak M; Li C; Ricordi C; Atkinson MA; Muzyczka N; Flotte TR
Gene Ther; 2003 Sep; 10(18):1551-8. PubMed ID: 12907946
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors.
Le Bec C; Douar AM
Gene Ther; 2006 May; 13(10):805-13. PubMed ID: 16453010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
